United Kingdom, London, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Introspective Market Research reports that the Active Implantable Medical Devices Market around the world was USD 25.48 billion in 2023 ...

United Kingdom, London, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Introspective Market Research reports that the Active Implantable Medical Devices Market around the world was USD 25.48 billion in 2023 and it ...

NANS attendees are invited to visit booth #213 to learn more about how Integer can serve as a strategic partner of choice in amplifying customers’ innovation and increasing speed to market. More ...

The MHRA has issued fresh guidance to help medical device manufacturers prepare for upcoming regulatory changes.

More specifically, Integer will showcase its latest innovations and expanded capabilities in neuromodulation to enable the next generation of miniaturized active implantable medical devices (AIMDs).

Part two enumerates the challenges faced with implantable systems. Biocompatibility, sterilization considerations and the development of active implantable medical devices in a regulated environment ...

More specifically, Integer will showcase its latest innovations and expanded capabilities in neuromodulation to enable the next generation of miniaturized active implantable medical devices (AIMDs).

This approval marks Alfapump as the first active implantable medical device for this condition in the US. Professor H.E. Vargas of the Mayo Clinic expressed the significance of this approval: “The FDA ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a suite of guidance specifically designed to help medical ...